deltatrials
Unknown PHASE2 INTERVENTIONAL 2-arm NCT02942420

Bucillamine Phase 2 Trial in Patients With Cystinuria

Phase 2 Multi-Center, Dose Escalation Trial To Assess The Safety And Effectiveness Of Bucillamine On Urinary Cystine Excretion And Cystine Capacity In Patients With Cystinuria

Sponsor: Revive Therapeutics, Ltd.

Conditions Cystinuria
Interventions Bucillamine
Updated 10 times since 2017 Last updated: May 16, 2017 Started: May 1, 2017 Primary completion: Mar 31, 2018 Completion: Mar 31, 2018
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02942420, this PHASE2 trial focuses on Cystinuria and remains ongoing. Sponsored by Revive Therapeutics, Ltd., it has been updated 10 times since 2017, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotNot Yet Recruiting~Feb 2017 – ~Mar 2017 · 28 days · monthly snapshotNot Yet Recruiting~Mar 2017 – ~Apr 2017 · 31 days · monthly snapshotRecruiting~Apr 2017 – ~Jun 2017 · 2 months · monthly snapshotRecruiting~Jun 2017 – ~Jun 2018 · 12 months · monthly snapshotRecruiting~Jun 2018 – ~Apr 2019 · 10 months · monthly snapshotRecruiting~Apr 2019 – ~Jan 2021 · 21 months · monthly snapshotUnknown Status~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – present · 22 months · monthly snapshotUnknown

Change History

10 versions recorded

  1. Sep 2024 — Present [monthly]

    Unknown PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE2

    Status: Unknown Status → Unknown

  3. Jan 2021 — Jul 2024 [monthly]

    Unknown Status PHASE2

  4. Apr 2019 — Jan 2021 [monthly]

    Unknown Status PHASE2

    Status: Recruiting → Unknown Status

  5. Jun 2018 — Apr 2019 [monthly]

    Recruiting PHASE2

▶ Show 5 earlier versions

  1. Jun 2017 — Jun 2018 [monthly]

    Recruiting PHASE2

  2. Apr 2017 — Jun 2017 [monthly]

    Recruiting PHASE2

  3. Mar 2017 — Apr 2017 [monthly]

    Recruiting PHASE2

    Status: Not Yet Recruiting → Recruiting

  4. Feb 2017 — Mar 2017 [monthly]

    Not Yet Recruiting PHASE2

  5. Jan 2017 — Feb 2017 [monthly]

    Not Yet Recruiting PHASE2

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Revive Therapeutics, Ltd.
Data source: Revive Therapeutics, Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations